{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Test%2FControl&page=88", "query": { "intervention": "Test/Control", "page": 88 }, "page_size": 10 }, "pagination": { "page": 88, "page_size": 10, "total_count": 4502, "total_pages": 451, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Test%2FControl&page=89&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Test%2FControl&page=87&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-02T15:03:46.256Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07731425", "title": "Patients' Expectations About the Survival Benefits of Cancer Drugs Approved Based on Progression-Free Survival", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cancer" ], "interventions": [ { "name": "FDA explanation for progression-free survival (control)", "type": "OTHER" }, { "name": "FDA explanation for progression-free survival with overall survival data", "type": "OTHER" }, { "name": "NCI explanation for progression-free survival", "type": "OTHER" }, { "name": "NCI explanation for progression-free survival with overall survival data", "type": "OTHER" }, { "name": "Plain-language explanation of progression-free survival", "type": "OTHER" }, { "name": "Plain-language explanation of progression-free survival with overall survival data", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "London School of Economics and Political Science", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3000, "start_date": "2026-08-01", "completion_date": "2026-10-01", "has_results": false, "last_update_posted_date": "2026-07-28", "last_synced_at": "2026-11-02T15:03:46.256Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07731425" }, { "nct_id": "NCT02968225", "title": "Using Serious Game Technology to Improve Sensitivity to Eye Gaze in Autism", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Autism" ], "interventions": [ { "name": "Computer Game", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Penn State University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "10 Years to 18 Years" }, "enrollment_count": 40, "start_date": "2016-08", "completion_date": "2018-10", "has_results": false, "last_update_posted_date": "2021-03-05", "last_synced_at": "2026-11-02T15:03:46.256Z", "location_count": 1, "location_summary": "University Park, Pennsylvania", "locations": [ { "city": "University Park", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02968225" }, { "nct_id": "NCT07619976", "title": "Effects of New Zealand Blackcurrant Supplementation on Exercise and Cognitive Performance in Resistance-Trained Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Resistance Exercise Performance", "Cognitive Function", "Anaerobic Performance", "Dietary Supplementation Athletic Performance" ], "interventions": [ { "name": "Low-dose Blackcurrant Supplement", "type": "DIETARY_SUPPLEMENT" }, { "name": "High-dose Blackcurrant Supplement", "type": "DIETARY_SUPPLEMENT" }, { "name": "Maltodextrin (Placebo)", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Jacksonville State University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "18 Years to 40 Years" }, "enrollment_count": 20, "start_date": "2023-01-21", "completion_date": "2023-07-10", "has_results": false, "last_update_posted_date": "2026-06-02", "last_synced_at": "2026-11-02T15:03:46.256Z", "location_count": 1, "location_summary": "Jacksonville, Alabama", "locations": [ { "city": "Jacksonville", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT07619976" }, { "nct_id": "NCT06141135", "title": "GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Infertility, Female" ], "interventions": [ { "name": "Preimplantation genetic testing for aneuploidy (PGTA)", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Genomic Prediction Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "40 Years", "sex": "FEMALE", "summary": "35 Years to 40 Years · Female only" }, "enrollment_count": 240, "start_date": "2023-11-15", "completion_date": "2026-11-15", "has_results": false, "last_update_posted_date": "2025-08-26", "last_synced_at": "2026-11-02T15:03:46.256Z", "location_count": 1, "location_summary": "Waltham, Massachusetts", "locations": [ { "city": "Waltham", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06141135" }, { "nct_id": "NCT02661633", "title": "Objective Brain Function Assessment of mTBI/Concussion in High School Athletes", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Brain Injuries, Traumatic", "Concussion, Brain", "Concussion, Mild", "Concussion, Intermediate", "Concussion, Severe" ], "interventions": [ { "name": "BrainScope Ahead 200iD", "type": "DEVICE" }, { "name": "Advanced MRI Neuroimaging", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "BrainScope Company, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "19 Years", "sex": "ALL", "summary": "13 Years to 19 Years" }, "enrollment_count": 177, "start_date": "2016-01-29", "completion_date": "2017-07-31", "has_results": false, "last_update_posted_date": "2019-05-23", "last_synced_at": "2026-11-02T15:03:46.256Z", "location_count": 4, "location_summary": "Fayetteville, Arkansas • Bethesda, Maryland • East Lansing, Michigan + 1 more", "locations": [ { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "East Lansing", "state": "Michigan" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02661633" }, { "nct_id": "NCT04501978", "title": "ACTIV-3: Therapeutics for Inpatients With COVID-19", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Covid19" ], "interventions": [ { "name": "LY3819253", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Remdesivir", "type": "BIOLOGICAL" }, { "name": "VIR-7831", "type": "BIOLOGICAL" }, { "name": "BRII-196/BRII-198", "type": "BIOLOGICAL" }, { "name": "AZD7442", "type": "BIOLOGICAL" }, { "name": "MP0420", "type": "DRUG" }, { "name": "PF-07304814", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2753, "start_date": "2020-08-04", "completion_date": "2023-07-14", "has_results": false, "last_update_posted_date": "2023-08-25", "last_synced_at": "2026-11-02T15:03:46.256Z", "location_count": 98, "location_summary": "Tucson, Arizona • Chula Vista, California • Fresno, California + 64 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Chula Vista", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "La Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04501978" }, { "nct_id": "NCT04193085", "title": "Wearable Technology to Assess Gait Function in SMA and DMD", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Spinal Muscular Atrophy Type 3", "Duchenne Muscular Dystrophy" ], "interventions": [ { "name": "Observational", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "5 Years", "maximum_age": null, "sex": "ALL", "summary": "5 Years and older" }, "enrollment_count": 39, "start_date": "2019-11-25", "completion_date": "2023-08-31", "has_results": false, "last_update_posted_date": "2024-09-23", "last_synced_at": "2026-11-02T15:03:46.256Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04193085" }, { "nct_id": "NCT03537248", "title": "A Safety and Effectiveness Study of a New Multi-Purpose Contact Lens Care Solution", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Contact Lens Wear" ], "interventions": [ { "name": "ASP-57", "type": "DEVICE" }, { "name": "ReNu® Multiplus", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Asepticys LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 315, "start_date": "2018-04-23", "completion_date": "2018-10-30", "has_results": false, "last_update_posted_date": "2019-02-11", "last_synced_at": "2026-11-02T15:03:46.256Z", "location_count": 14, "location_summary": "Irvine, California • San Diego, California • Longwood, Florida + 11 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Longwood", "state": "Florida" }, { "city": "Maitland", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03537248" }, { "nct_id": "NCT03382015", "title": "Effect of BKR-013 on Average Daily Glucose Levels", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "BKR-013 or Placebo", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "BioKier Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 14, "start_date": "2018-01-09", "completion_date": "2018-06-30", "has_results": false, "last_update_posted_date": "2018-08-10", "last_synced_at": "2026-11-02T15:03:46.256Z", "location_count": 1, "location_summary": "Baton Rouge, Louisiana", "locations": [ { "city": "Baton Rouge", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT03382015" }, { "nct_id": "NCT05327452", "title": "Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Cancer", "Colorectal Cancer", "Prostate Cancer" ], "interventions": [ { "name": "Supervised Home-Based Exercise", "type": "BEHAVIORAL" }, { "name": "Unsupervised Home-Based Exercise", "type": "BEHAVIORAL" }, { "name": "Attention Control", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 135, "start_date": "2022-10-31", "completion_date": "2027-05-31", "has_results": false, "last_update_posted_date": "2026-01-21", "last_synced_at": "2026-11-02T15:03:46.256Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05327452" } ] }